Clinical Investigator - NCI Designated Cancer Center

Clinical Investigator – Medical Oncology

The University of Kansas Cancer Center is seeking to recruit a full time academic Clinical Investigator with demonstrated interest in investigational drug development and Phase I Clinical Trials. The successful candidate will join a translational team of physicians and scientists focused on early clinical development of personalized cancer therapeutics. The selected candidate will be integrated into the academic and teaching activities of the KU Clinical Research Center, the Divisions of Medical Hematology Oncology, HMCT and KUCC research programs.

Qualified applicants will be physicians at the Assistant/Associate Professor level, board certified/eligible in medical oncology or hematology/oncology, and eligible for licensure in Kansas. Must have a proven ability to develop experimental cancer therapies and conduct innovative, investigator-initiated early-phase clinical trials.

The University of Kansas Cancer Center is on an urgent journey to break the devastating grip of cancer. We are the only National Cancer Institute-designated cancer center in the region, and 1 of only 71 in the nation, to receive this elite distinction.

Cancer is our sole focus. With 350 cancer researchers and clinicians, and 150-plus disease-specific oncologists, we are elevating standards in cancer care. We provide unrivaled expertise and experience in diagnosing and treating all forms of cancer, from common and complex to rare.

Working in an academic medical center setting, our nationally and internationally renowned investigators conduct pivotal research that propels science forward, leading to improvements in cancer prevention, diagnosis, treatment and survivorship. These intense efforts are crucial to our most important mission: to achieve the best possible outcome for every patient who trusts in our care.